CClinicalTrials.gg
Not yet recruitingNCT07472829Updated Mar 17, 2026

Research on Speech Development Trajectories and Predictive Models in Children With Autism Spectrum Disorder

An observational study in Speech and Autism Spectrum Disorder (ASD), sponsored by Children's Hospital of Chongqing Medical University. Not yet recruiting. Open to participants aged 18 Months to 60 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-17.

Sponsored by Children's Hospital of Chongqing Medical University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
120
Ages
18 Months to 60 Months
Sex
All
01

Study summary

Recent studies indicate that children with ASD have a significantly higher risk of co-occurring speech sound disorders than typically developing children. Early atypical speech development may be a critical yet overlooked bottleneck hindering their language improvement. Given the unique phonetic features of Mandarin, it is essential to investigate speech development in Mandarin-speaking children with ASD. This study aims to construct developmental trajectories and establish early identification and prognosis prediction models for this population.

Read the detailed description
  1. Procedures. This study plans to enroll 60 children with autism spectrum disorder (ASD group) and 60 typically developing children (TD group), aged 18-60 months, matched by age and sex. At baseline, both groups will undergo assessments of development, language, and parent-child interaction, as well as fNIRS; the ASD group will additionally receive clinical diagnostic evaluations. Subsequently, a one-year follow-up will be conducted, with both groups completing language and parent-child interaction assessments at 3, 6, 9, and 12 months, and undergoing repeated developmental and fNIRS evaluations at the final 12-month visit.
  2. Demographic questionnaire and clinical data. The demographic questionnaire is completed by the child's primary caregiver, detailing child's name, gender, date of birth, height, weight, heart rate. Clinical data will be ascertained from the medical records, including information about DSM-5 diagnosis and comorbid conditions.
  3. Sample size. This study ultimately determined a sample size of 120 participants (60 in the ASD group and 60 in the TD group). The estimation was based on the minimum sample size required to analyze the "group × time" interaction effect using a mixed-effects model (88 participants, achieving 85% power), and fully considered the following factors: ① Meeting the analytical requirements for both the main effects of group and time; ② The need to increase the sample size to 110 participants if multiple comparison corrections (Bonferroni correction, α=0.0083) are applied to the six speech indicators; ③ Considering practical operational challenges such as the long follow-up period, multiple repeated measurements, and anticipated dropout rates, the sample was ultimately expanded to 120 participants to ensure the robustness of the study.
  4. Statistical analysis. SPSS 25.0 software (SPSS Inc) was used for statistical analysis for the scale data, The speech development trajectories of the two groups can be analyzed using longitudinal methods such as mixed-effects models. Repeated measures ANOVA will compare speech characteristics between the ASD and TD groups at five time points (baseline, 3, 6, 9, and 12 months). Correlation analysis (Pearson or Spearman, depending on normality) will assess the relationship between speech development and core ASD symptoms. ANOVA/MANOVA will examine group differences in speech perception tasks, and exploratory factor analysis will identify underlying factors influencing speech perception.All statistical analyses were conducted with a statistical threshold P-value of \<0.05. The data collected through fNIRS will be performed via NirSpark analysis software.
  5. Ethical matters and data protection. The children participated in the study will sign the informed consent (obtained from the guardian). And this study was approved by the local ethics committee. children's name will be abbreviated and the research data will be assigned a code then to provide to the researcher. The authorization from parents on the children's health information remains valid until the study is completed. After that, researchers will delete private information from the study record.
02

Conditions studied

  • Speech
  • Autism Spectrum Disorder (ASD)
03

Who can participate

Ages eligible
18 Months to 60 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

TD group

Inclusion criteria

  • Diagnosed as typically developing children by two or more associate chief physicians.
  • Gender- and age-matched to the ASD group.
  • Participants whose native language is Chinese.

Exclusion criteria

Exclusion Criteria:

  • Participants not meeting the age requirement.
  • Presence of orofacial motor and swallowing dysfunction.
  • Hearing impairment.
  • Participants whose native language isn't Chinese.
  • Neurological disorders (such as encephalitis or seizures) and comorbid psychiatric disorders.
04

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
120 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • ASD group

    Inclusion criteria: Diagnosed by two or more associate chief physicians using the DSM-5 diagnostic criteria. Participants aged between 18 and 60 months. Participants with a vocabulary size ranging from 0 to 50 words, as assessed using the Chinese Communicative Development Inventory. Participants whose native language is Chinese. Exclusion criteria: Participants not meeting the age requirement. Presence of orofacial motor and swallowing dysfunction. Hearing impairment. Participants whose native language isn't Chinese. Neurological disorders (such as encephalitis or seizures) and comorbid psychiatric disorders.

    Behavioral: Approaches to ASD social intervention

  • TD group

    Inclusion Criteria: Diagnosed as typically developing children by two or more associate chief physicians. Gender- and age-matched to the ASD group. Participants whose native language is Chinese. Exclusion Criteria: Participants not meeting the age requirement. Presence of orofacial motor and swallowing dysfunction. Hearing impairment. Participants whose native language isn't Chinese. Neurological disorders (such as encephalitis or seizures) and comorbid psychiatric disorders.

Interventions

  • BehavioralApproaches to ASD social intervention

    The intervention methods for children in the ASD group will be documented in detail (through telephone or online follow-ups, based on parental reports, with records including the location, time, frequency, and main content of the interventions); children in the TD group did not receive any intervention.

05

What researchers measure

Primary outcomes

  1. The language ability of ASD group and TD group by Dream-it

    The participants will be assessed using the Dream-it, which consists of two separate scales developed for children aged 0-18 months and 18-36 months, respectively. The assessment is conducted via parent report and completed on an iPad. The evaluation covers four domains: language comprehension, language expression, cognitive play, and social communication.The researchers will calculate the participants' scale scores across four dimensions and compare them at different time points.

    Time frame: Baseline enrollment;3 months ,6 months ,9 months and 12 months after follow-up

  2. The language ability of ASD group and TD group by free-play session with one parent

    The participants will be engage in a 15-minute semi-structured free-play session with one parent, which will be video-recorded for later coding of behavioral and vocalization measures. The investigators will collect the participant's naturalistic language. Indicators such as the diversity of syllables, the number of vowels, and the number of consonants will be calculated and compared at various time points.

    Time frame: Baseline enrollment; 3 months, 6 months, 9 months and 12 months after follow-up

Secondary outcomes

  1. The changes in degree of ASD disorder by Autism Diagnostic Observation Schedule-2

    The participants in ASD group will be accepted the ADOS assessment.The Autism Diagnostic Observation Schedule-2 (ADOS-2) is adopted to assess the changes in the degree of ASD disorder. The Autism Diagnostic Observation Schedule-2 (ADOS-2) is a standardized observational assessment. The assessment includes abilities in four areas: social interaction, stereotypical behavior, verbal communication, emotion, and abnormal behavior. The participants in the study will be administered a module 1 for children with little or no phrase speech or Module 2, for children who use phrase speech but are not yet fluent. Standardized ADOS scores in the domains of social affect (SA) and restricted repetitive behaviors (RRB) were calculated as indicators of ASD severity.

    Time frame: Baseline enrollment; 12 months after follow-up

  2. The developmental level in ASD group and TD group

    The participants will be assessed using the Gesell Developmental Schedule (GESELL) .The Gesell assessment is a developmental evaluation tool for young children, typically used from birth to age six, to measure skills across fine motor, gross motor, adaptive, language, and personal-social domains.Scores for the five domains (gross motor, fine motor, adaptive, language, and personal-social) will be calculated and compared between groups.

    Time frame: Baseline enrollment; 12 months after follow-up

  3. The changes of brain function detection indicators

    To assess speech perception, two groups of participants will be completed a task-based paradigm while being monitored with functional near-infrared spectroscopy (fNIRS).All participants will undergo an approximately 10-minute speech perception task, during which concentrations of oxygenated hemoglobin in different brain regions and functional connectivity will be recorded.

    Time frame: Baseline enrollment;12 months after follow-up

06

Study locations

No study locations are listed for this record.

07

References and documents

Publications

  • DeVeney SL, Kyvelidou A, Mather P. A home-based longitudinal study of vocalization behaviors across infants at low and elevated risk of autism. Autism Dev Lang Impair. 2021 Nov 24;6:23969415211057658. doi: 10.1177/23969415211057658. eCollection 2021 Jan-Dec. PubMed 36440373 ↗
  • Chenausky KV, Maffei M, Tager-Flusberg H, Green JR. Review of methods for conducting speech research with minimally verbal individuals with autism spectrum disorder. Augment Altern Commun. 2023 Mar;39(1):33-44. doi: 10.1080/07434618.2022.2120071. Epub 2022 Nov 8. PubMed 36345836 ↗
  • Yankowitz LD, Petrulla V, Plate S, Tunc B, Guthrie W, Meera SS, Tena K, Pandey J, Swanson MR, Pruett JR Jr, Cola M, Russell A, Marrus N, Hazlett HC, Botteron K, Constantino JN, Dager SR, Estes A, Zwaigenbaum L, Piven J, Schultz RT, Parish-Morris J; IBIS Network. Infants later diagnosed with autism have lower canonical babbling ratios in the first year of life. Mol Autism. 2022 Jun 27;13(1):28. doi: 10.1186/s13229-022-00503-8. PubMed 35761377 ↗
  • Helland WA, Lundervold AJ, Heimann M, Posserud MB. Stable associations between behavioral problems and language impairments across childhood - the importance of pragmatic language problems. Res Dev Disabil. 2014 May;35(5):943-51. doi: 10.1016/j.ridd.2014.02.016. Epub 2014 Mar 15. PubMed 24642228 ↗
  • Liu M, Han J, Zhang Y, Wen J, Wang Y, Hu X, Sun M, Qu L, Han X, Xu L, Zhao H, Lu H, Liu Q. Phonological Development in 3-6-Year-Old Mandarin-Speaking Children with Autism, Developmental Delays, and Typical Development. J Autism Dev Disord. 2025 Dec;55(12):4312-4323. doi: 10.1007/s10803-024-06522-z. Epub 2024 Aug 23. PubMed 39177934 ↗

Individual participant data

Plan to share: No — Data is confidential during the study.

08

Registry details

Key details

Study ID
NCT07472829
Lead sponsor
Children's Hospital of Chongqing Medical University
Responsible party
Chen Li (Professor, Director, Children's Hospital of Chongqing Medical University) — Principal investigator
First posted
Mar 16, 2026
Start date
Mar 10, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Mar 17, 2026

Study contacts

Li Chen, Doctor
Contact
chenli@cqmu.edu.cn
13677620103 ext. +86

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion